BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weaver TE, Drake CL, Benes H, Stern T, Maynard J, Thein SG, Andry JM Sr, Hudson JD, Chen D, Carter LP, Bron M, Lee L, Black J, Bogan RK. Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial. Ann Am Thorac Soc 2020;17:998-1007. [PMID: 32353246 DOI: 10.1513/AnnalsATS.202002-136OC] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Ngo Q, Plante DT. An Update on the Misuse and Abuse Potential of Pharmacological Treatments for Central Disorders of Hypersomnolence. Curr Sleep Medicine Rep. [DOI: 10.1007/s40675-022-00227-4] [Reference Citation Analysis]
2 Zhang W, Tocher P, L'Heureux J, Sou J, Sun H. Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review. Value Health 2022:S1098-3015(22)02070-8. [PMID: 35961865 DOI: 10.1016/j.jval.2022.06.015] [Reference Citation Analysis]
3 Vinckenbosch F, Asin J, de Vries N, Vonk PE, Donjacour CEHM, Lammers GJ, Overeem S, Janssen H, Wang G, Chen D, Carter LP, Zhou K, Vermeeren A, Ramaekers JG. Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea. Hum Psychopharmacol 2022;:e2845. [PMID: 35633275 DOI: 10.1002/hup.2845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 El-Solh AA, Rudraraju A, Pasrija D, Bui H. Pharmacotherapy of residual excessive sleepiness among continuous positive airway pressure (CPAP) treated patients with sleep apnea. Expert Opin Pharmacother 2022;:1-10. [PMID: 35045769 DOI: 10.1080/14656566.2022.2029408] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ishikawa O, Hahn S, Greenberg H; Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA. Pharmacologic Therapy for Narcolepsy. Neurology 2022;18:68. [DOI: 10.17925/usn.2022.18.1.68] [Reference Citation Analysis]
6 Weaver TE, Pepin JL, Schwab R, Shapiro C, Hedner J, Ahmed M, Foldvary-Schaefer N, Strollo PJ, Mayer G, Sarmiento K, Baladi M, Bron M, Chandler P, Lee L, Malhotra A. Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. J Clin Sleep Med 2021;17:1995-2007. [PMID: 34606437 DOI: 10.5664/jcsm.9384] [Reference Citation Analysis]
7 Fietze I, Blum H, Grüger H, Käßner F, Maurer JT, Nilius G, Penzel T, Triché D, Arzt M. Diagnostik und Therapie der residualen Tagesschläfrigkeit bei Patienten mit therapierter obstruktiver Schlafapnoe. Somnologie 2021;25:99-109. [DOI: 10.1007/s11818-021-00305-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Abad VC. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Nat Sci Sleep 2021;13:75-91. [PMID: 33531850 DOI: 10.2147/NSS.S245020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
9 Zomorodi K, Chen D, Lee L, Swearingen D, Carter LP. A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants. Clin Pharmacol Drug Dev 2021;10:404-13. [PMID: 32935460 DOI: 10.1002/cpdd.867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]